Bioenergetic modulators hamper cancer cell viability and enhance response to chemotherapy.

Journal of Cellular and Molecular Medicine
Diana Tavares-ValenteOdília Queirós

Abstract

Gliomas are characterized by a marked glycolytic metabolism with a consequent production of massive amounts of lactate, even in the presence of normal levels of oxygen, associated to increased invasion capacity and to higher resistance to conventional treatment. This work aimed to understand how the metabolic modulation can influence tumour aggressive features and its potential to be used as complementary therapy. We assessed the effect of bioenergetic modulators (BMs) targeting different metabolic pathways in glioma cell characteristics. The in vivo effect of BMs was evaluated using the chicken chorioallantoic membrane model. Additionally, the effect of pre-treatment with BMs in the response to the antitumour drug temozolomide (TMZ) was analysed in vitro. Cell treatment with the BMs induced a decrease in cell viability and in migratory/invasion abilities, as well as modifications in metabolic parameters (glucose, lactate and ATP) and increased the cytotoxicity of the conventional drug TMZ. Furthermore, all BMs decreased the tumour growth and the number of blood vessels in an in vivo model. Our results demonstrate that metabolic modulation has the potential to be used as therapy to decrease the aggressiveness of the tumours or ...Continue Reading

References

May 19, 1995·Journal of Chromatography. B, Biomedical Applications·F ShenF Lejeune
Jul 27, 2002·The Lancet Oncology·Markus Bredel, Josef Zentner
Mar 28, 2003·Neoplasia : an International Journal for Oncology Research·Paul A Schornack, Robert J Gillies
Jun 28, 2003·FEBS Letters·D Grahame HardieEmma R Hudson
Feb 24, 1956·Science·O WARBURG
Oct 31, 2003·Cancer Treatment Reviews·Hiroto IzumiKimitoshi Kohno
Feb 8, 2006·The Journal of Pathology·R Abdel-FattahI M Hussaini
Feb 17, 2007·The FEBS Journal·Rafael Moreno-SánchezEmma Saavedra
Feb 20, 2007·Molecular Cancer Therapeutics·Johnathan C MaherTheodore J Lampidis
Aug 10, 2007·British Journal of Cancer·R A GatenbyR J Gillies
Jun 10, 2008·Cancer Cell·Guido Kroemer, Jacques Pouyssegur
Jun 20, 2008·Journal of Neuro-oncology·Pedram TabatabaeiA Tommy Bergenheim
Sep 4, 2008·British Journal of Cancer·E D MichelakisJ R Mackey
Dec 10, 2009·Molecular Aspects of Medicine·Feng WangPeng Huang
Apr 2, 2010·Nature Reviews. Cancer·Nilay Shah, Saraswati Sukumar
May 14, 2010·Science Translational Medicine·E D MichelakisK C Petruk
May 21, 2010·British Journal of Cancer·B M MadhokD G Jayne
May 27, 2010·Cancer Chemotherapy and Pharmacology·Dirk HesheClaudia Lanvers-Kaminsky
Jun 12, 2010·Cancer Letters·Siranoush ShahrzadBrenda L Coomber
Aug 13, 2011·Nature Reviews. Cancer·Bradley A WebbDiane L Barber
Sep 10, 2011·Frontiers in Pharmacology·Paolo E PorporatoPierre Sonveaux
Mar 21, 2012·Cancer Research·Gang ChengBalaraman Kalyanaraman
Jun 12, 2012·ChemMedChem·Carlotta Granchi, Filippo Minutolo
Dec 22, 2012·Neuro-oncology·Vera Miranda-GonçalvesFátima Baltazar
Jul 3, 2013·Journal of Bioenergetics and Biomembranes·Diana Tavares-ValenteOdília Queirós
Nov 1, 2013·Endocrine-related Cancer·Filipa Morais-SantosCéline Pinheiro
Jan 28, 2014·PloS One·W Keith MiskiminsJoon Young Choi
May 21, 2014·ELife·William W WheatonNavdeep S Chandel

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Clinical Trials Mentioned

NCT01111097

Software Mentioned

Cell B
GraphPad
GraphPad prism
Image J

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.